The Flowr Company Announces Export Agreement to Israel with Aim Professional medical Herbs and IM Cannabis

Highlights:

• Flowr to export up to 500 kilograms of premium health-related hashish to Israel.

• The Supply Agreement signifies the Company’s very first export opportunity into an global market place.

TORONTO, June 07, 2021 (World NEWSWIRE) — The Flowr Company (TSX.V: FLWR OTC: FLWPF) (“Flowr” or the “Enterprise”) is pleased to announce that it has entered into a source agreement (“Provide Settlement”) with Aim Health-related Herbs Ltd. (“Target Health care”), a organization which IM Hashish Corp. (NASDAQ: IMCC) (CSE:IMCC) (“IMC”) has an distinctive professional arrangement with in Israel. Pursuant to the phrases of the Source Arrangement, a wholly-owned subsidiary of Flowr has agreed to export up to 5 hundred kilograms of top quality dry flower hashish in bulk kind into Israel. The Offer Agreement signifies the Company’s to start with major global distribution agreement and initial export chance into Israel.

The Israeli health care cannabis sector was characterized by powerful calendar year-above-12 months expansion in 2020. In accordance to Prohibition Companions, active patients grew by approximately 17% from 2019 to 2020, achieving about 70,000 people, primary to imports into Israel of more than 7 tonnes by July 2020. Israel also announced options to legalize recreational hashish in late 2020, which will even more travel demand from customers for substantial-quality hashish merchandise. Brightfield estimates the market will deliver around U.S.$130 million in 2021 and achieve about U.S.$230 million by 2025.

“We are really pleased to be introducing our cannabis to the Israeli market place in partnership with IMC and Target Professional medical,” commented Darryl Brooker, Chief Government Officer of Flowr. “We expect the Israeli market place to be an important desired destination for us to develop our brand and distribution reach internationally. Coupled with our potential to expand high THC quality dry flower from our E.U. GMP amenities in Portugal, we perspective this partnership as an critical following phase to turning out to be a major global producer of hashish with a globally regarded brand.”

Tale carries on

“IMC and Focus Clinical have picked to spouse with Flowr mainly because of its popularity as a premium hashish producer in Canada and abroad,” commented Oren Shuster, Chief Executive Officer of IMC. “We imagine that the Israeli sector will get Flowr’s renowned BC Pink Kush and BC Black Cherry strains with open up arms. We appear forward to operating with the Flowr workforce to sector and sell these high quality and extremely-top quality choices.”

The Business expects its to start with shipment of BC Pink Kush to be readily available in the Israeli current market in H2, 2021. The partnership with Focus Health care is for a time period of 3 several years, topic to particular early termination provisions and applicable regulatory needs such as the receipt of import and export permits.

About Flowr

The Flowr Corporation is a Toronto-headquartered hashish business with functions in Canada, and Europe. Its Canadian functioning campus, located in Kelowna, BC, consists of a function-designed, GMP-developed indoor cultivation facility an outside and greenhouse cultivation internet site and a condition-of-the-art R&D facility. From this campus, Flowr provides recreational and medicinal products. Internationally, Flowr intends to support the global health-related hashish current market through its subsidiary Holigen Holdings Confined, which has a license for cannabis cultivation in Portugal and operates a GMP certified facility in Portugal. In 2020, Flowr’s BC Pink Kush was identified as the top indica strain in Canada by Type journal.

Flowr aims to assist improving upon outcomes through liable hashish use and, as an proven expert in cannabis cultivation, strives to be the brand name of selection for people and people trying to find the optimum-top quality craftsmanship and products consistency across a portfolio of differentiated cannabis products.

For much more information, please pay a visit to flowrcorp.com or observe Flowr on Twitter: @FlowrCanada and LinkedIn: The Flowr Corporation.

About Concentrate Health care

Focus Medical is just one of 8 original accredited producers of professional medical cannabis in Israel and has around 10 decades of knowledge escalating higher high-quality professional medical cannabis in the Israeli market. Aim Healthcare has an exclusive commercial arrangement with IMC to distribute its output less than the IMC brand name. In addition to its have potential, Focus Health-related has signed source agreements with other cultivators for additional source employing its proprietary genetics and for sale below the IMC model.

About IMC

IMC is an MCO in the healthcare and adult-use recreational hashish sector, headquartered in Israel and with operations In Israel, Germany and Canada. Above the previous 10 years, the Company thinks that the IMC brand has come to be synonymous with good quality and consistency in the Israeli health care hashish sector. The Business has also expanded its small business to offer intellectual assets-connected expert services to the medical cannabis marketplace.

In Europe, IMC operates through Adjupharm GmbH (“Adjupharm”), a German-primarily based subsidiary and EU GMP-qualified health care cannabis processor and distributor. IMC’s European existence is augmented by strategic alliances with numerous pan-European EU-GMP cultivators and distributors to capitalize on the improved need for medical hashish items in Europe and carry the IMC model and its solution portfolio to European sufferers.

In Canada, IMC operates by way of Trichome JWC Acquisition Corp. (d/b/a “JWC”). JWC is a accredited producer positioned in Kitchener, Ontario, selling hashish flower, pre-rolls, hash and kief in the Canadian recreational cannabis market place less than the JWC and Wagners manufacturers. JWC operates with higher specifications for providing clean, regular, aeroponically-developed premium hashish solutions to professional medical clients and the adult-use sector throughout Canada and the planet. On March 31, 2021, IMC entered into a definitive arrangement to get MYM and its accredited producer subsidiary, Highland Mature Inc. This transaction, if done, will boost IMC’s target of getting a major international top quality cannabis producer and purveyor.

On behalf of The Flowr Company:

Darryl Brooker
Main Executive Officer

Get in touch with Information and facts:

Buyers & MEDIA:
John Chou
Main Financial Officer
[email protected]

Ahead-On the lookout Facts:

Certain statements designed in this press launch may well constitute “forward-wanting information”, “future oriented money information” or “financial outlooks” (collectively, “ahead-hunting info”) within the that means of relevant securities guidelines. Ahead-searching information and facts might relate to anticipated functions or success like, but not minimal to: the Company’s expectation that it will make on its achievements as it proceeds to devote in profits and marketing the Company’s expectations for sales of item in Quebec Flowr servicing the world-wide health care cannabis market and operating GMP facilities in Portugal Flowr’s small business, output and products Flowr’s plans to give premium top quality hashish to adult use leisure and clinical marketplaces EU-GMP certification opening the medicinal hashish opportunity for the Firm in world markets the Company getting perfectly positioned to distribute EU-GMP compliant solution into underserviced markets Flowr’s means to recognize income from the Company’s European operations within the predicted timeframe or at all Flowr’s capability to set up revenue and distribution channels in Europe to supply medicinal cannabis to underserviced marketplaces expectations with respect to the expected timing for harvests, propagation, completion of building and set up of extraction infrastructure at the Company’s Sintra facility the Organization becoming unable to begin GMP packaging and commercial profits in just the expected timeframe or at all Flowr’s capability to services the worldwide professional medical hashish current market and/or operate GMP-built production facilities in Portugal the sale of professional medical cannabis in pharmacies in Portugal symbolizing a watershed moment for cannabis in the E.U. the Company’s capacity to full supplying(s) of its securities less than the Closing Shelf Prospectus the anticipated effects of the strategic review selections on the Corporation the precise charges of savings from the Company’s restructuring initiatives, like with respect to its workforce the Company’s options to divest its interests in sure of its subsidiaries the Company’s skill to acquire licensing from Wellness Canada and other regulatory authorities with regard to its properties and facilities future legislative and regulatory developments in Canada and elsewhere the cannabis business in Canada generally the capacity of Flowr to apply its company procedures and the ability of Flowr to produce or provide top quality high-quality hashish. Significantly, facts with regards to our anticipations of upcoming outcomes, targets, effectiveness achievements, potential customers or chances is ahead-seeking information. Frequently, but not always, ahead-on the lookout statements can be recognized by the use of ahead-searching terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “plan”, “could”, “should”, “would”, “outlook”, “forecast”, “anticipate”, “foresee”, “continue” or the destructive of these terms or versions of them or similar terminology. Ahead-searching facts is recent as of the date it is produced and is based on sensible estimates and assumptions manufactured by us at the pertinent time in gentle of our encounter and perception of historic traits, existing problems and predicted long run developments, as properly as other aspects that we imagine are acceptable and affordable in the situation. To the extent any ahead-looking facts in this push release constitutes “future oriented money information” or “financial outlooks”, within the that means of relevant securities legislation, the goal of such information and facts being supplied is to display the probable of the Company and viewers are cautioned that this data may possibly not be ideal for any other purpose. However, we do not undertake to update any these types of ahead-seeking data whether as a outcome of new details, foreseeable future activities or otherwise, except as required beneath relevant securities regulations in Canada. There can be no assurance that this sort of estimates and assumptions will prove to be suitable. A lot of aspects could trigger our precise outcomes, level of exercise, effectiveness or achievements or long run functions or developments to differ materially from people expressed or implied by the ahead-on the lookout facts as discussed in the “Risk Factors” section of the Company’s 2020 Once-a-year Details Variety dated April 28, 2021 (the “AIF”). A copy of the AIF and the Company’s other publicly filed files can be accessed underneath the Company’s profile on the Process for Electronic Document Examination and Retrieval (“SEDAR”) at www.sedar.com. The Organization cautions that the listing of risk variables and uncertainties explained in the AIF is not exhaustive and other variables could also adversely influence its benefits. Readers are urged to think about the challenges, uncertainties and assumptions diligently in analyzing the forward-hunting data and are cautioned not to location undue reliance on such information.

Neither TSX Enterprise Exchange nor its Regulation Solutions Provider (as that phrase is defined in policies of the TSX Undertaking Trade) accepts responsibility for the adequacy or accuracy of this launch.